15 Jan From $5 to $750 million: LIFE Healthcare's bold gamble pays off with massive return on alzheimer's diagnostic sale
30 MIN
Download (14.3 MB)
Life Healthcare’s bold $5 acquisition of a pioneering Alzheimer’s diagnostic company has led to a stunning $750 million payoff. CEO Peter Wharton-Hood reflects on the strategic risks and rewards, highlighting the company’s focused future in Southern Africa’s healthcare sector, while navigating challenges like National Health Insurance.